Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment
NCT02111434
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Hypogonadism
Interventions
DRUG:
Testosterone
Sponsor
Gulhane School of Medicine